SFX by Ex Libris Inc.

Title:	SUMO1-dependent modulation of SERCA2a in heart failure
Source:	Nature [0028-0836] Kho, C yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ylä-Herttuala, S. "Gene transfer as a tool to induce therapeutic vascular growth." Nature medicine 9.6 (2003): 694-701.
description	2.	Byrne, M.J. J. "Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals." Gene therapy 15.23 (2008): 1550-7.
description	3.	Arnold R, R. "Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health." Social science & medicine 61.10 (2005): 2144-2154.
description	4.	Raake, W. "Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors." Gene therapy 15.1 (2008): 12-17.
description	5.	Fishman, K R R. "Fashioning the vertebrate heart: earliest embryonic decisions." Development 124.11 (1997): 2099-117.
description	6.	Ylä-Herttuala, S. "Cardiovascular gene therapy." The lancet 355.9199 (1999): 213-222.
description	7.	Caroci, Adelaide de Souza S. "Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure." Heart & lung 33.2 (2004): 102-110.
description	8.	Narsavage, G L L. "Factors associated with referral of elderly individuals with cardiac and pulmonary disorders for home care services following hospital discharge." Journal of gerontological nursing 26.5 (2000): 14-20.
description	9.	Jauhiainen, S. "Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors." Expert opinion on biological therapy 12.1 (2011): 79-92.
description	10.	Yl-Herttuala, S. "New aspects in vascular gene therapy." Current opinion in pharmacology 10.2 (2010): 208-211.
description	11.	Kapur, Navin K K. "Fibroblast Growth Factor 4 Gene Therapy for Chronic Ischemic Heart Disease." Trends in Cardiovascular Medicine 18.4 (2008): 133-41.
description	12.	Henry TD, Edward R R. "The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis." Circulation 107.10 (2003): 1359-65.
description	13.	Kuster, G. "Redox-mediated reciprocal regulation of SERCA and Na+-Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes." Free radical biology & medicine 48.9 (2010): 1182-1187.
description	14.	Ly, Roger Q. "In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction." European Heart Journal 30.23 (2009): 2861-8.
description	15.	Rodriguez-Martinez, S. "LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes." International journal of dermatology 47.5 (2008): 457-462.
description	16.	Kaczmarek, M. "Assessment of VEGF-receptor system expression in the porcine endometrial stromal cells in response to insulin-like growth factor-I, relaxin, oxytocin and prostaglandin E-2." Molecular and Cellular Endocrinology 291.1-2 (2008): 33-41.
description	17.	Gupta, Mahesh P P. "Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure." Journal of Molecular and Cellular Cardiology 43.4 (2007): 388-403.
description	18.	Wang, X. "Cre transgenic mouse lines." Methods in molecular biology 561 (2009): 265-73.
description	19.	Roubos, N.. "Repair of postmyocardial infarct ventricular free wall rupture using an onlay pericardial patch." The Asia Pacific heart journal 8.2 (1999): 110-114.
description	20.	Yoshino, H. "Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume." Gene therapy 13.24 (2006): 1696-1702.